Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study
ContributorsIncremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP)Working Group
CollaboratorsBoccardi, Marina; Altomare, Daniele; Ferrari, Clarissa; Festari, Cristina; Frisoni, Giovanni
Published inJAMA neurology, vol. 73, no. 12, p. 1417-1424
Publication date2016
Abstract
Keywords
- Aged
- Aged, 80 and over
- Alzheimer Disease/diagnosis/diagnostic imaging/metabolism
- Amyloid beta-Peptides/metabolism
- Aniline Compounds
- Cognitive Dysfunction/diagnosis/diagnostic imaging/metabolism
- Ethylene Glycols
- Female
- Humans
- Male
- Positron-Emission Tomography/methods/standards
- Predictive Value of Tests
Affiliation entities
Research groups
Citation (ISO format)
Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP)Working Group. Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study. In: JAMA neurology, 2016, vol. 73, n° 12, p. 1417–1424. doi: 10.1001/jamaneurol.2016.3751
Main files (1)
Article (Published version)
Identifiers
- PID : unige:95508
- DOI : 10.1001/jamaneurol.2016.3751
- PMID : 27802513
Journal ISSN2168-6149
